GPR139 Agonist

JNJ-63533054 is a potent, selective and orally active GPR139 agonist with an EC₅₀ of 16 nM for human GPR139 (hGPR139). JNJ-63533054 shows selective for GPR139 over other GPCRs, ion channels, and transporters. JNJ-63533054 can cross the blood-brain barrier (BBB).

Zelatriazin (TAK-041; NBI-1065846) is a potent and selective GPR139 agonist with an EC₅₀ of 22 nM. Zelatriazin has the potential for the research of negative symptoms associated with schizophrenia.

TC-O 9311 is a potent orphan G protein-coupled receptor 139 (GPR139) agonist with an EC₅₀ of 39 nM.

GPR139 agonist-2 (compound 20a) is a potent GPR139 agonist with an EC₅₀ of 24.7 nM. GPR139 agonist-2 rescues the social interaction deficits and alleviates cognitive deficits in murine schizophrenia models. GPR139 agonist-2 has the potential for antischizophrenia drug research.

TC-O 9311 (Standard) is the analytical standard of TC-O 9311 (HY-101777). This product is intended for research and analytical applications. TC-O 9311 is a potent orphan G protein-coupled receptor 139 (GPR139) agonist with an EC₅₀ of 39 nM.